At a glance
- Originator Nonindustrial source
- Class Cardiotonics
- Mechanism of Action Beta-adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias
Most Recent Events
- 14 Jan 2000 No-Development-Reported for Arrhythmias in Taiwan (Unknown route)
- 16 Dec 1996 New profile
- 16 Dec 1996 Preclinical development for Arrhythmias in Taiwan (Unknown route)